Merck KGaA (MRK.DE)
-XETRA 117.95 
2.60(2.25%) 11:35AM EDT
| Prev Close: | 115.35 |
|---|
| Open: | 115.25 |
|---|
| Bid: | 117.80 |
|---|
| Ask: | 117.85 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 115.15 - 118.10 |
|---|
| 52wk Range: | 96.41 - 128.50 |
|---|
| Volume: | 250,418 |
|---|
| Avg Vol (3m): | 208,023 |
|---|
| Market Cap: | 25.64B |
|---|
| P/E (ttm): | 24.58 |
|---|
| EPS (ttm): | 4.80 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- Merck KGaA's Drug Tops Roche's Avastin for Colon Cancerat Bloomberg(Sat, Sep 28)
- Merck KGaA Names Garijo to Run Serono Biotechnology Unitat Bloomberg(Thu, Sep 26)
- Stocks to Watch: Mako Surgical, Ascena, Oncothyreonat The Wall Street Journal(Wed, Sep 25)
- Glaxo MAGE-A3 Cancer Drug Fails to Help Patients in Trialat Bloomberg(Thu, Sep 5)
- GSK cancer vaccine disappoints in melanoma trialat Reuters(Thu, Sep 5)
- German Stocks Drop Before ECB Monetary-Policy Decisionat Bloomberg(Thu, Sep 5)
- Q2 2013 Merck KGaA Earnings Release - 01:00 am ETCCBN(Tue, Aug 6)
- Merck back to profits on lower one-time costsAP(Tue, Aug 6)
- Merck KGaA Falls Most in Three Months as Sales Declineat Bloomberg(Tue, Aug 6)
- Merck KGaA says to seek takeover deals more actively from 2014at Reuters(Tue, Aug 6)
- Merck KGaA Q2 adj core profit up on liquid crystalsat Reuters(Tue, Aug 6)
- German stocks - Factors to watch on August 6at Reuters(Tue, Aug 6)
- Mylan’s 2013 Sales to Be at Low End of Forecast, CFO Saysat Bloomberg(Thu, Aug 1)
- Charity’s Largest-Ever Lung Cancer Effort Seeks Causesat Bloomberg(Wed, Jul 17)
- German chemicals sector lowers sales outlook for 2013at Reuters(Thu, Jul 11)
Reports
- No Reports available for MRK.DE at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.22 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Merck KGaA operates as a pharmaceutical, chemical, and life science company worldwide. It operates through four divisions: Merck Serono, Consumer Health, Performance Materials, and Merck Millipore.
View More